2796
Pharmarise Holdings Corporation
ファーマライズホールディングス
- Industry
- Retail Trade
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
May 2022
51,608
May 2023
52,030
May 2024
54,466
May 2025
63,508
May 2026
69,512
Operating profit(million JPY)
May 2022
1,520
May 2023
1,438
May 2024
916
May 2025
293
May 2026
979
Operating profit margin(%)
May 2022
2.95
May 2023
2.76
May 2024
1.68
May 2025
0.46
May 2026
1.41
Profit before tax(million JPY)
May 2022
1,322
May 2023
1,049
May 2024
143
May 2025
8
May 2026
698
Profit(million JPY)
May 2022
447
May 2023
333
May 2024
-351
May 2025
-367
May 2026
114
Total assets(million JPY)
May 2022
23,746
May 2023
23,421
May 2024
29,486
May 2025
31,924
May 2026
32,680
Cash and cash equivalents(million JPY)
May 2022
3,991
May 2023
4,734
May 2024
7,100
May 2025
4,891
May 2026
6,012
Cash flows from operating activities(million JPY)
May 2022
713
May 2023
2,520
May 2024
2,714
May 2025
1,311
May 2026
3,278
Cash flows from investing activities(million JPY)
May 2022
-292
May 2023
-703
May 2024
-3,120
May 2025
-4,462
May 2026
-1,975
Cash flows from financing activities(million JPY)
May 2022
-1,034
May 2023
-1,072
May 2024
2,771
May 2025
939
May 2026
-181
Return on equity(%)
May 2022
7.2
May 2023
5.1
May 2024
-5.1
May 2025
-5.3
May 2026
1.7
Equity ratio(%)
May 2022
26.9
May 2023
28.5
May 2024
24.3
May 2025
20.9
May 2026
20.3
Earnings per share(JPY per share)
May 2022
47.99
May 2023
35.45
May 2024
-33.41
May 2025
-32.48
May 2026
10.01
Net assets per share(JPY per share)
May 2022
684.2
May 2023
708.01
May 2024
636.25
May 2025
586.21
May 2026
576.71
Dividend per share(JPY per share)
May 2022
14
May 2023
14
May 2024
20
May 2025
14
May 2026
14
Payout ratio(%)
May 2022
29.17
May 2023
39.49
May 2024
-
May 2025
-
May 2026
139.86
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.